CSL (ASX:CSL) share price remains near 52-week low on COVID-19 vaccine delays

The CSL Limited (ASX: CSL) share price is failing to make a meaningful comeback after spending months moving sideways. The global biotech’s shares finished yesterday market session at $263.60, just 8% above its 52-week low reached in early March. At the time of writing, the CSL share price is up slightly, trading for $263.69.

Below, we take a closer look at what could be weighing down CSL shares.

COVID-19 vaccine delay

While most of the world looks towards advancing past the COVID-19 pandemic, Australia has been locked in vaccine holdups. This comes after a reported 2.5 million AstraZeneca doses are being kept in cold storage…